Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials-Reference-Cited by-同舟云学术

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials

Published:2015-10 Issue:10 Volume:25 Page:898-905
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Russell-Jones D.,Gall M.-A.,Niemeyer M.,Diamant M.,Del Prato S.

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference31 articles.

1. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemic management;Leiter;Can J Diabetes,2005

2. Addressing barriers to initiation of insulin in patients with type 2 diabetes;Peyrot;Prim Care Diabetes,2010

3. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people;Khunti;Diabetes Care,2013

4. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir;Peterson;Curr Med Res Opin,2006

5. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with type 1 diabetes;Bolli;Nutr Metab Cardiovasc Dis,2009

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin degludec in pregestational diabetes: evidence and perspectives;Archives of Medical Science – Atherosclerotic Diseases;2024-05-10

2. Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications;Journal of Clinical Medicine;2024-04-05

3. Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2024-03-21

4. Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U‐100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring;Journal of Diabetes Investigation;2024-01-23

5. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11